Patents by Inventor Xue-Jun Kong

Xue-Jun Kong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250108077
    Abstract: Disclosed herein are methods and compositions useful for the treatment of subjects suffering from Prader-Willi Syndrome (PWS). The methods include administering compositions comprising probiotics, such as Lactobacillus reuteri (L. reuteri) and Bifidobacterium animalis subsp. lactis (B. Lactis) to subjects in need thereof.
    Type: Application
    Filed: December 6, 2024
    Publication date: April 3, 2025
    Applicant: The General Hospital Corporation
    Inventor: Xue-Jun Kong
  • Publication number: 20250041364
    Abstract: Disclosed herein are methods and compositions useful for the treatment of subjects suffering from Prader-Willi Syndrome (PWS). The methods include administering compositions comprising probiotics, such as Lactobacillus reuteri (L. reuteri) and Bifidobacterium animalis subsp. lactis (B. Lactis) to subjects in need thereof.
    Type: Application
    Filed: August 5, 2024
    Publication date: February 6, 2025
    Applicant: The General Hospital Corporation
    Inventor: Xue-Jun Kong
  • Publication number: 20250000918
    Abstract: The present disclosure provides a method for treating symptoms of Prader-Willi Syndrome (PWS). The method includes administering a probiotic composition to the subject. The present disclosure further includes a. method, for determining an efficacy of a probiotic composition to treat PWS in a subject. The present disclosure further includes a kit. The kit includes a probiotic composition for oral administration and a detection molecule for the detection one or more microorganisms.
    Type: Application
    Filed: October 25, 2022
    Publication date: January 2, 2025
    Applicant: The General Hospital Corporation
    Inventor: Xue-Jun Kong
  • Publication number: 20240100104
    Abstract: Disclosed herein are methods and compositions useful for the treatment of Autism Spectrum Disorder (ASD). The methods and compositions include combination therapy with probiotics and oxytocin (OXT), resulting in a therapeutic synergy that exerts beneficial effects on ASD symptoms. The methods and compositions provide improvements in several measurable parameters including but not limited to: measured clinical index for ASD core symptoms, gut microbiome profile, and levels of OXT and inflammatory markers in the blood.
    Type: Application
    Filed: December 30, 2021
    Publication date: March 28, 2024
    Inventor: Xue-Jun Kong
  • Publication number: 20240050494
    Abstract: Disclosed herein are methods and compositions useful for the treatment of subjects suffering from Prader-Willi Syndrome (PWS). The methods include administering compositions comprising probiotics, such as Lactobacillus reuteri (L. reuteri) and Bifidobacterium animalis subsp. lactis (B. lactis) to subjects in need thereof.
    Type: Application
    Filed: December 17, 2021
    Publication date: February 15, 2024
    Inventor: Xue-Jun Kong